Meloxicam Completed Phase 4 Trials for Biliary Atresia, Kasai Portoenterostomy Status Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02298218Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia